NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Fabry disease


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
2009 AUG 17 ... was marked by a significant achievement for Amicus with our lead program, Amigal for Fabry disease, entering Phase 3 development." Crowley continued, "This is a major step for the ...
Subject: Therapy
Price: $3.00
*
Data on fabry disease detailed by R. Schiffmann and co-authors
2009 AUG 10 ... to recent research published in the journal Nephrology Dialysis Transplantation, "In Fabry disease, progressive glycolipid accumulation leads to organ damage and early demise, but the ...
Subject: Fabry Disease
Price: $3.00
*
Data on fabry disease published by R.L. Lieberman and colleagues
2009 AUG 10 ... and mutations in these enzymes lead to the lipid metabolism disorders Gaucher and Fabry disease, respectively. We have investigated the structure and stability of GCase and alpha-Gal A ...
Subject: Fabry Disease
Price: $3.00
*
Data on stroke discussed by O. Lidove and colleagues
2009 NOV 23 ... According to recent research from Paris, France, "Fabry disease (OMIM 301 500) is an X-linked lysosomal storage disease. Neurological symptoms in...
Subject: Stroke
Price: $3.00
*
Findings from R. Fabry and co-researchers advance knowledge in intermittent claudication
2009 NOV 1 ... walking distance in patients with moderate intermittent claudication," wrote R. Fabry and colleagues. The researchers concluded: "This effect, which was ... Care Medicine, Intermittent Claudication, Quality of Life, Therapy, Treatment, Vascular Disease. This article was prepared by Pharma Investments, Ventures & Law Weekly ...
Subject: Intermittent Claudication
Price: $3.00
*
Genzyme Provides Update on Cerezyme and Fabrazyme Supply
2009 OCT 5 ... patient demand through October. Dose conservation guidelines were implemented by the Fabry physician and patient community to help ensure that the reduced product supply was ... The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune disease, and diagnostic testing. Genzyme's ...
Subject: Genzyme Corporation
Price: $3.00
*
New breast cancer study findings have been reported by scientists at Attikon University, Department of Surgery
2009 NOV 23 ... Many great surgeons of that time (including Pare, Cabrol, Servetto, Scultetus, Tulp, Fabry von Hilded, etc.) advanced the science of surgery. Interestingly, Bartoleny Gabrol ... of Cancer Care. According to a study from Athens, Greece, "Cancer was known as a disease since prehistoric times. Management of breast cancer evolved slowly through centuries in ...
Subject: Breast Cancer
View Free
Daily News
Article
New fabry disease study findings recently were reported by researchers at Johann Wolfgang Goethe University
2009 AUG 10 ... According to a study from Mainz, Germany, "Although Fabry disease is X linked and considered to affect primarily male hemizygotes, female heterozygotes ...
Subject: Fabry Disease
Price: $3.00
*
New life sciences study results reported from J.M. Politei et al
2009 OCT 12 ... According to a study from Buenos Aires, Argentina, "Fabry disease is a rare, X-linked lysosomal storage disease caused by an inborn deficiency of ...
Subject: Life Sciences
Price: $3.00
*
Reports from Ewha Womans University highlight recent research in fabry disease
2009 OCT 12 ... According to recent research from Seoul, South Korea, "Fabry disease is a lysosomal storage disease caused by a deficiency of alpha-galactosidase A, which ...
Subject: Fabry Disease
Price: $3.00
*
Research conducted by M. Imbriaco and co-researchers has updated our knowledge about fabry disease
2009 AUG 3 ... "Anderson-Fabry disease is a multisystem X linked disorder of lipid metabolism frequently associated with ...
Subject: Fabry Disease
Price: $3.00
*
Research in the area of mass spectrometry reported from University of Florence
2009 AUG 31 ... blood spots from 10 patients affected by ''Pompe'', 6 by ''Gaucher'', 12 by ''Fabry'', 3 by ''Niemann-Pick'' A/B, and 2 by ''Krabbe'' diseases. Reference values ... normal range. In heterozygous carriers (18 for Fabry, 10 for Pompe, and 4 for Gaucher disease) the activities were slightly lower than in control subjects," wrote G. Lamarca and ...
Subject: Mass Spectrometry
Price: $3.00
*
Researchers from University of Michigan describe findings in enzyme research
2009 NOV 9 ... "Fabry disease is a lysosomal storage disorder that results in an accumulation of globotriaosylceramide ...
Subject: Enzyme Research
Price: $3.00
*
Scientists at University of Amsterdam release new data on fibrinolysis
2009 NOV 9 ... "In Fabry disease, storage of globotriaosylceramide (Gb3) in arterial walls is one of the main ...
Subject: Fibrinolysis
Price: $3.00
*
Shire Targets Fourth Quarter Filing of BLA for REPLAGAL for Fabry Disease With U.S. FDA
2009 NOV 2 ... for REPLAGAL® (agalsidase alfa), its enzyme replacement therapy for Fabry disease, by the end of the year. The Company also announces that a treatment protocol for ...
Subject: Shire Plc
Price: $3.00
*
Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
2009 NOV 2 ... (FDA) for REPLAGAL® (agalsidase alfa), its enzyme replacement therapy for Fabry disease, by the end of the year. The Company also announces that a treatment protocol for ...
Subject: Fabry Disease
Price: $3.00
*
Study data from T. Okuda and colleagues update understanding of fabry disease
2009 NOV 1 ... globotriaosylceramide (Gb3) is known to be associated with Gb3-related diseases, such as Fabry disease. The Gb3 synthase gene (Gb3S) codes for alpha 1,4-galactosyltransferase, which is a key ...
Subject: Fabry Disease
Price: $3.00
*
Study findings on fabry disease are outlined in reports from University College
2009 SEP 14 ... "Fabry disease is a rare X-linked lysosomal storage disorder characterised by severe multisystemic ...
Subject: Fabry Disease
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login